James Liddy

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get HEPA alerts

About James Liddy

James Liddy is recorded as Board Member at Hepion Pharmaceuticals, Inc. (HEPA) since August 19, 2026. Hepion Pharmaceuticals, Inc. reported in an 8-K filed August 20, 2026 that James Liddy was appointed director, effective August 19, 2026. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Dr. Kaouthar Lbiati (CEO), Gary Stetz (CEO, CFO and Board Member), John Cavan (CEO and CFO) and 7 others.

“On August 19, 2026, the Board of Directors of Hepion Pharmaceuticals, Inc. (the "Company") approved the appointment of James Liddy as a director of the Company, effective immediately.”

Hepion Pharmaceuticals, Inc. Form 8-K, filed August 20, 2026 · Read the filing

Affiliation history

Hepion Pharmaceuticals, Inc. (HEPA)
Board Member

SEC 8-K

Current
2026-08-19–present

Company network

Hepion Pharmaceuticals, Inc.

HEPA

Current role

Biotechnology · Healthcare

Board Member

2026-08-19–present

Leadership on record at Hepion Pharmaceuticals, Inc.

Dr. Kaouthar Lbiati CEO
Gary Stetz CEO, CFO, Board Member
John Cavan CEO, CFO
Kaouthar Lbiati CEO, Board Member
Sireesh Appajosyula CEO, Board Member
John Brancaccio Chairman, CFO
Vincent LoPriore Chairman
Chase LoPriore Board Member
Danina Fisher Board Member
Gary S. Stetz, II Board Member

Recent activity

Executive change Appointed: director Hepion Pharmaceuticals, Inc. (HEPA)
2026-08-19